Christopher B. Ehrlich - Feb 14, 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc. (EFTR)

Role
Director
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Christopher B. Ehrlich
Stock symbol
EFTR
Transactions as of
Feb 14, 2022
Transactions value $
$13,200
Form type
4
Date filed
2/22/2022, 03:59 PM
Previous filing
Feb 10, 2022
Next filing
Jun 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFTR Common Stock Purchase $8.9K +2K +15.38% $4.45 15K Feb 14, 2022 Direct F1
transaction EFTR Common Stock Purchase $4.3K +1K +6.67% $4.30 16K Feb 18, 2022 Direct
holding EFTR Common Stock 142K Feb 14, 2022 By Locust Walk Partners LLC F2
holding EFTR Common Stock 1.03K Feb 14, 2022 By Locust Walk Partners LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in two transactions at prices ranging from $4.40 to $4.50. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 Represents shares held directly by the Sponsor, of which Locust Walk Partners LLC ("LWP") is a member. LWP has allocated these shares to the reporting person.
F3 Represents shares held directly by the Sponsor, of which LWP is a member. LWP has allocated these shares to the reporting person's spouse.